Digan, Lauriana M.
HRN: 17-09-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2025
CEFTRIAXONE 1G (VIAL)
09/06/2025
09/13/2025
IV
2g
OD
Acute Pyelonephritis
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines